Northwestern Mutual Wealth Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-287	Closed	-$3K	–	2626
2016 Q4	$3K	Buy	+287	New	+$2.87K	﹤0.01%	2010
2016 Q3	–	Sell	-287	Closed	-$4K	–	1896
2016 Q2	$4K	Hold	287	–	–	﹤0.01%	1710
2016 Q1	$3K	Buy	+287	New	+$2.55K	﹤0.01%	1847

Other funds holding SCLN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northwestern Mutual Wealth Management's SCLN Position: Q1 2017 in Review

Northwestern Mutual Wealth Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q1 2017, closing a stake of 287 shares — an estimated $3K sold.

Northwestern Mutual Wealth Management first reported a position in SCLN in Q1 2016 and held it in 3 quarters. The position peaked at $4K in Q2 2016. 136 funds tracked by Wall St. Rank hold SCLN as of Q1 2017.

Northwestern Mutual Wealth Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 287 Sciclone Pharmaceuticals Inc shares in Q1 2017, an estimated $3K.
Northwestern Mutual Wealth Management first reported a position in Sciclone Pharmaceuticals Inc in Q1 2016 and held it in 3 quarters.
Northwestern Mutual Wealth Management's Sciclone Pharmaceuticals Inc position peaked at $4K in Q2 2016.
136 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q1 2017.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.